Gilead’s Veklury® (Remdesivir) Demonstrates Expanded Clinical Benefits for Treatment of COVID-19 - Colorado Bioscience Association

This topic is empty.

Viewing 1 post (of 1 total)

Author

Posts
10/13/2020 at 11:33 am #11154

Colorado BioScience Association
Keymaster

The findings from the ACTT-1 trial for the company’s investigational antiviral were published in the New England Journal of Medicine.

More Information
Author

Posts

Viewing 1 post (of 1 total)

You must be logged in to reply to this topic.